Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kennelly

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Toxins|May 27, 2025
Intravesical Onabotulinum Toxin A Injection Paradigms for Idiopathic Overactive Bladder: A Scoping Review of Clinical Outcomes, Techniques, and Implications for Practice and Future ResearchEkene Enemchukwu, Hodan Mohamud, Shada Sinclair, et al.
Neurourology and Urodynamics|February 26, 2011
Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladderEric Rovner, Michael Kennelly, Heinrich Schulte-Baukloh, et al.
Spinal Cord Series and Cases|November 6, 2018
International spinal cord injury urodynamic basic data set (version 2.0)Jürgen Pannek, Michael Kennelly, Thomas M Kessler, et al.
Urogynecology (Philadelphia, Pa.)|March 19, 2026
Relaxing Environment Lowers Anxiety During Chemodenervation: a Randomized TrialErin Franks, Joseph Rigdon, Michael Kennelly, et al.
Neurourology and Urodynamics|June 17, 2021
Using conjoint analysis to measure the importance of psychosocial traits in the choices of bladder management after spinal cord injuryBlayne Welk, Jeremy B Myers, Michael Kennelly, et al.
Spinal Cord Series and Cases|July 14, 2018
International Spinal Cord Injury Lower Urinary Tract Function Basic Data Set (version 2.0)Fin Biering-Sørensen, Michael Kennelly, Thomas M Kessler, et al.
Journal of Clinical Medicine|August 26, 2023
New Intermittent Urinary Micro-Hole Zone Catheter Shows Enhanced Performance in Emptying the Bladder: A Randomised, Controlled Crossover StudyMalene Hornbak Landauro, Lotte Jacobsen, Fabio Tentor, et al.
Advances in Therapy|March 23, 2024
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims AnalysisBenjamin Chastek, Adam Carrera, Christina Landis, et al.
Neurourology and Urodynamics|May 9, 2024
Comparative analysis of real-world adherence and persistence patterns with vibegron, mirabegron, and anticholinergics in patients with overactive bladder: A retrospective claims studyBenjamin Chastek, Adam Carrera, Christina Landis, et al.
BJU International|February 1, 2017
Positive outcomes with first onabotulinumtoxinA treatment persist in the long term with repeat treatments in patients with neurogenic detrusor overactivityPierre Denys, Roger Dmochowski, Philip Aliotta, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Toxins|May 27, 2025
Intravesical Onabotulinum Toxin A Injection Paradigms for Idiopathic Overactive Bladder: A Scoping Review of Clinical Outcomes, Techniques, and Implications for Practice and Future ResearchEkene Enemchukwu, Hodan Mohamud, Shada Sinclair, et al.
Neurourology and Urodynamics|February 26, 2011
Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladderEric Rovner, Michael Kennelly, Heinrich Schulte-Baukloh, et al.
Spinal Cord Series and Cases|November 6, 2018
International spinal cord injury urodynamic basic data set (version 2.0)Jürgen Pannek, Michael Kennelly, Thomas M Kessler, et al.
Urogynecology (Philadelphia, Pa.)|March 19, 2026
Relaxing Environment Lowers Anxiety During Chemodenervation: a Randomized TrialErin Franks, Joseph Rigdon, Michael Kennelly, et al.
Neurourology and Urodynamics|June 17, 2021
Using conjoint analysis to measure the importance of psychosocial traits in the choices of bladder management after spinal cord injuryBlayne Welk, Jeremy B Myers, Michael Kennelly, et al.
Spinal Cord Series and Cases|July 14, 2018
International Spinal Cord Injury Lower Urinary Tract Function Basic Data Set (version 2.0)Fin Biering-Sørensen, Michael Kennelly, Thomas M Kessler, et al.
Journal of Clinical Medicine|August 26, 2023
New Intermittent Urinary Micro-Hole Zone Catheter Shows Enhanced Performance in Emptying the Bladder: A Randomised, Controlled Crossover StudyMalene Hornbak Landauro, Lotte Jacobsen, Fabio Tentor, et al.
Advances in Therapy|March 23, 2024
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims AnalysisBenjamin Chastek, Adam Carrera, Christina Landis, et al.
Neurourology and Urodynamics|May 9, 2024
Comparative analysis of real-world adherence and persistence patterns with vibegron, mirabegron, and anticholinergics in patients with overactive bladder: A retrospective claims studyBenjamin Chastek, Adam Carrera, Christina Landis, et al.
BJU International|February 1, 2017
Positive outcomes with first onabotulinumtoxinA treatment persist in the long term with repeat treatments in patients with neurogenic detrusor overactivityPierre Denys, Roger Dmochowski, Philip Aliotta, et al.
Pageof 4